# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001401914-20-000020
Filing Date
2020-02-06
Accepted
2020-02-06 08:52:49
Documents
5
Period of Report
2020-02-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | dare8-k.htm | 8-K | 26580
2 | EXHIBIT 99.1 | ex991.htm | EX-99.1 | 10255
3 |  | ex991001.jpg | GRAPHIC | 226878
4 |  | ex991002.jpg | GRAPHIC | 309319
5 |  | ex991003.jpg | GRAPHIC | 114525
| Complete submission text file | 0001401914-20-000020.txt |  | 934561

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 20581122
SIC: 2834 Pharmaceutical Preparations